BR9507437A - Base livre de halofantrina e composições para o tratamento da malária - Google Patents

Base livre de halofantrina e composições para o tratamento da malária

Info

Publication number
BR9507437A
BR9507437A BR9507437A BR9507437A BR9507437A BR 9507437 A BR9507437 A BR 9507437A BR 9507437 A BR9507437 A BR 9507437A BR 9507437 A BR9507437 A BR 9507437A BR 9507437 A BR9507437 A BR 9507437A
Authority
BR
Brazil
Prior art keywords
treatment
free base
halofantrine
malaria
compositions
Prior art date
Application number
BR9507437A
Other languages
English (en)
Inventor
William Neil Charman
Christopher John Hamilt Porter
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9406858A external-priority patent/GB9406858D0/en
Priority claimed from GB9416404A external-priority patent/GB9416404D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR9507437A publication Critical patent/BR9507437A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9507437A 1994-04-07 1995-04-04 Base livre de halofantrina e composições para o tratamento da malária BR9507437A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9406858A GB9406858D0 (en) 1994-04-07 1994-04-07 New use and formulations
GB9416404A GB9416404D0 (en) 1994-08-13 1994-08-13 New use and formulations
PCT/EP1995/001257 WO1995027492A1 (en) 1994-04-07 1995-04-04 Halofantrine free base for the treatment of malaria and compositions

Publications (1)

Publication Number Publication Date
BR9507437A true BR9507437A (pt) 1997-09-16

Family

ID=26304653

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507437A BR9507437A (pt) 1994-04-07 1995-04-04 Base livre de halofantrina e composições para o tratamento da malária

Country Status (16)

Country Link
US (1) US5968987A (pt)
EP (1) EP0754045B1 (pt)
JP (1) JPH09512794A (pt)
CN (1) CN1145030A (pt)
AT (1) ATE213937T1 (pt)
AU (1) AU685263B2 (pt)
BR (1) BR9507437A (pt)
CA (1) CA2187185A1 (pt)
CZ (1) CZ293696A3 (pt)
DE (1) DE69525740T2 (pt)
ES (1) ES2170143T3 (pt)
HU (1) HUT76051A (pt)
NO (1) NO964238L (pt)
NZ (1) NZ284068A (pt)
PL (1) PL179608B1 (pt)
WO (1) WO1995027492A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5340298A (en) * 1996-12-27 1998-07-31 Takeda Chemical Industries Ltd. Stabilized tricyclic compound
US6979456B1 (en) * 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
IN191696B (pt) * 1999-02-12 2003-12-20 Council Scient Ind Res
US6616942B1 (en) * 1999-03-29 2003-09-09 Soft Gel Technologies, Inc. Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
US6759058B1 (en) * 2001-04-25 2004-07-06 Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences Enteric-coated proliposomal formulations for poorly water soluble drugs
AUPR573001A0 (en) * 2001-06-15 2001-07-12 Glaxo Wellcome Australia Ltd Lymphatic drug delivery system
AU2002343555A1 (en) 2001-11-14 2003-05-26 Texas Tech University Eutectic-based self-nanoemulsified drug delivery system
US20060148776A1 (en) * 2003-03-13 2006-07-06 Conforma Therapeutics Corporation Drug formulations having long and medium chain triglycerides
US8124072B2 (en) 2003-09-29 2012-02-28 Soft Gel Technologies, Inc. Solubilized CoQ-10
WO2005032278A1 (en) 2003-09-29 2005-04-14 Soft Gel Technologies, Inc. SOLUBILIZED CoQ-10
US20050220866A1 (en) * 2004-04-02 2005-10-06 Dr. Reddy's Laboratories Limited Novel capsule formulations of etoposide for oral use
US8343541B2 (en) 2007-03-15 2013-01-01 Soft Gel Technologies, Inc. Ubiquinol and alpha lipoic acid compositions
SA109300195B1 (ar) 2008-03-28 2013-04-20 Astrazeneca Ab تركيبة صيدلانية جديدة مضادة للسرطان
CA2690490C (en) * 2010-01-19 2012-06-26 Accucaps Industries Limited Pharmaceutical formulations of loratadine for encapsulation and combinations thereof
US9309136B2 (en) * 2014-06-12 2016-04-12 Tersus Environmental, Llc Bioremediation of soil and groundwater
ES2851332T3 (es) * 2014-06-19 2021-09-06 Solural Pharma ApS Forma sólida de dosificación oral de compuestos lipofílicos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818767A (en) * 1983-11-02 1989-04-04 Smithkline Beckman Corporation Quinate salts of antimalarial phenanthrenemethanol compounds
US4507288A (en) * 1983-09-16 1985-03-26 Smithkline Beckman Corporation β-Glycerophosphate salts of antimalarial phenanthrenemethanol compounds
US5278173A (en) * 1988-06-30 1994-01-11 Davis Michael H Method of inhibiting the activity of human immunodeficiency virus (HIV) in vivo
AP9200405A0 (en) * 1991-07-15 1994-01-13 Smithkline Beecham Ag Pharmaceutical formulations comprised of micronised halofantrine.

Also Published As

Publication number Publication date
AU685263B2 (en) 1998-01-15
DE69525740D1 (de) 2002-04-11
NZ284068A (en) 1998-06-26
NO964238D0 (no) 1996-10-04
NO964238L (no) 1996-10-04
PL179608B1 (pl) 2000-10-31
ES2170143T3 (es) 2002-08-01
US5968987A (en) 1999-10-19
AU2256895A (en) 1995-10-30
PL316656A1 (en) 1997-02-03
CZ293696A3 (en) 1997-01-15
DE69525740T2 (de) 2002-10-24
ATE213937T1 (de) 2002-03-15
HU9602740D0 (en) 1996-11-28
EP0754045A1 (en) 1997-01-22
EP0754045B1 (en) 2002-03-06
JPH09512794A (ja) 1997-12-22
CA2187185A1 (en) 1995-10-19
MX9604611A (es) 1997-11-29
HUT76051A (en) 1997-06-30
WO1995027492A1 (en) 1995-10-19
CN1145030A (zh) 1997-03-12

Similar Documents

Publication Publication Date Title
BR9507437A (pt) Base livre de halofantrina e composições para o tratamento da malária
BR0112962A (pt) Composições farmacêuticas para o tratamento de condições inflamatórias e ulcerativas dolorosas de maioria das superfìcies epiteliais tais como mucosite, estomatite e sìndrome de behcet
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
BR9908020A (pt) Fórmula para polimento ótico
FR2766176B1 (fr) Compositions a base de derives de resveratrol
SE9802729D0 (sv) Novel Compounds
BR9900320A (pt) Composição antimicrobiana
ES2193337T3 (es) Utilizacion de sales de estroncio para el tratamiento de la artrosis.
DE60110342D1 (de) Alpha-Interferon enthaltende Hautpflegemittel
ATE273690T1 (de) Zusammensetzung zur hautdesinfizierung
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
BR0315437A (pt) Composição para o tratamento dos cabelos, usos da mesma e método para o tratamento dos cabelos
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
BR9611727A (pt) Derivados de quínolina anti-malária
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
NO20010940D0 (no) TAN-1057 derivater
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
NO20021573D0 (no) Tverrbundne kopolymerer basert på ikke-tverrbundne polykarboksylkopolymerer
DE69831737D1 (de) Neurotrypsin
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
BR9902081A (pt) Combinação de dofetilida e um bloqueador dos canais de cálcio

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/00 (2006.01), A61K 9/107 (2006.0